S. Zhang

BRCA1 mRNA levels following a 4–6-week intervention with oral 3,3′-diindolylmethane

L. Salmena, S. Narod, J. Kotsopoulos, 2014, British Journal of Cancer.

Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21.

L. Norton, M. Moynahan, A. Houghton, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Objective response of first-line chemotherapy of triple-negative breast cancer translates into survival benefit: an analysis in an independent, prospective clinical trial and a real-world setting.

T. Li, Y. Zhu, J. Zhang, 2020, Neoplasma.

Screening for BRCA1 and BRCA2 mutations among French‐Canadian breast cancer cases attending an outpatient clinic in Montreal

A. Robidoux, S. Narod, P. Ghadirian, 2014, Clinical genetics.

Prevalence of PALB2 mutations in the Creighton University Breast Cancer Family Registry

S. Narod, H. Lynch, K. Metcalfe, 2015, Breast Cancer Research and Treatment.

The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas

Akbari, S. Narod, J. Hurley, 2014, Clinical genetics.

Absence of constitutional H2AX gene mutations in 101 hereditary breast cancer families

A. Monteiro, S. Narod, C. Phelan, 2003, Journal of medical genetics.

The contribution of founder mutations to early‐onset breast cancer in French‐Canadian women

A. Robidoux, F. Rousseau, M. Akbari, 2009, Clinical genetics.

Evaluation of the Metasin assay for intraoperative assessment of sentinel lymph node metastases in breast cancer

E. Hodges, R. Cutress, S. Zhang, 2016, Journal of Clinical Pathology.

Prevalence of founder mutations in the BRCA1 and BRCA2 genes among unaffected women from the Bahamas

M. Akbari, J. Hurley, D. Halliday, 2016, Clinical genetics.